ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETF vs SBI Healthcare Opportunities Fund

ABSL vs SBI· Portfolio Overlap Analysis

53.5%High Overlap
12 common stocksRank #7503 / 20,000

Investor takeaway: At 53.5% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.

Common Holdings (12)

StockWt% in ADITYA BIRLA SUN LIFE NIFTY HEWt% in SBI Healthcare OpportunitiesOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
18.36%10.65%10.65%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
8.13%7.55%7.55%
Apollo Hospitals Enterprise Limited
Healthcare Services
8.04%5.76%5.76%
Max Healthcare Institute Limited
Healthcare Services
8.11%4.82%4.82%
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
4.52%4.25%4.25%
Lupin Limited
Pharmaceuticals & Biotechnology
5.57%4.23%4.23%
Laurus Labs Limited
Pharmaceuticals & Biotechnology
4.17%3.48%3.48%
Fortis Healthcare Limited
Healthcare Services
4.90%3.24%3.24%
Biocon Limited
Pharmaceuticals & Biotechnology
2.78%3.59%2.78%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
3.29%2.77%2.77%
Mankind Pharma Ltd
Pharmaceuticals & Biotechnology
2.54%2.98%2.54%
Abbott India Limited
Pharmaceuticals & Biotechnology
1.38%1.95%1.38%

Unique to ADITYA BIRLA SUN LIFE NIFTY HE

  • Dr. Reddys Laboratories Limited7.82%
  • Cipla Limited7.57%

Unique to SBI Healthcare Opportunities

  • Acutaas Chemicals Ltd.4.77%
  • Aster DM Healthcare Ltd.3.85%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
39.6% (9)
Healthcare Services
13.8% (3)

More comparisons for ADITYA BIRLA SUN LIFE NIFTY HE

More comparisons for SBI Healthcare Opportunities

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.